Study findings published in BMC Medicine show that increasing albuminuria, decreasing estimated glomerular filtration rate, and worsening stages of chronic kidney disease are independently associated with increased risk for stroke in people with type 2 diabetes.
Research published in JAMA suggests the risk for dementia increases with younger age at type 2 diabetes diagnosis, with the risk further increased in people who have a stroke.
A Mendelian analysis supports a causal effect of hyperglycemia on stroke risk, and the researchers also pinpoint the medications most likely to reduce this risk.
Real-world study findings suggest that heart failure is associated with the greatest increase in mortality risk when compared with other cardiovascular and renal complications among people with newly diagnosed type 2 diabetes.
An exploratory analysis of stroke outcomes in the REWIND trial indicates that dulaglutide may reduce the incidence but not severity of ischemic stroke in people with type 2 diabetes.
A lower than currently recommended blood pressure target may be necessary to reduce the risk for stroke in people with type 1 diabetes, say researchers.
Delaying diabetes onset by at least 6 years in people with impaired glucose tolerance significantly reduces their risk for cardiovascular disease and microvascular complications, show 30-year data from the Da Qing Diabetes Prevention Study.